For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Kindness and teamwork are key to daily successes

GLAXOSMITHKLINE PRACTICE OR BUSINESS MANAGER OF THE YEAR AWARD
GlaxoSmithKline NZ and GSK Consumer Healthcare are pleased to be supporting the practice or business manager category this year. Within the primary care setting, from general practice to community pharmacy, there are many individuals who work across clinical and business needs. These individuals ensure health
providers, services, programmes and products deliver the best possible health outcomes for the individuals and communities they serve. GSK is proud to recognise
those outstanding business managers at these awards
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.